531223
Anjani Synthetics Ltd-$
BSELast Traded Price
₹25.70
-0.30 (-1.15%)
Open
₹26.39
High
₹26.40
Low
₹24.71
Prev Close
₹26.00
Industry
Textiles
Market Cap
37.91 Cr
Filing History
Recent corporate announcements and filings for 531223
Governance
Neutral
2026-08-12 19:22
- Appointment of Mr. Azizbhai Hasanbhai Gohil as Company Secretary & Compliance Officer effective 25th August 2026.
- Re-appointment of M/s. Shah & Shah Associates as Secretarial Auditor for FY 2026-27 to FY 2030-31.
- Re-appointment of M/s. Kiran J Mehta & Co. as Cost Auditor for FY 2026-27.
- Re-appointment of M/s. ACM & Associates as Internal Auditor for FY 2026-27.
Governance
Neutral
2026-08-12 19:09
- Board of Directors approved the appointment of Mr. Azizbhai Hasanbhai Gohil as Company Secretary and Compliance Officer, effective August 25, 2026.
- Re-appointment of M/s. Shah & Shah Associates as Secretarial Auditor for FY 2026-27 to FY 2030-31.
- Re-appointment of M/s. Kiran J Mehta & Co. as Cost Auditor for FY 2026-27.
- Re-appointment of M/s. ACM & Associates as Internal Auditor for FY 2026-27.
Financials
Positive
2026-08-12 18:44
- Q1 FY27 Standalone Revenue ₹6,950.66 Lacs vs ₹6,136.04 Lacs (▲13.3% YoY)
- EBITDA ₹233.97 Lacs vs ₹235.73 Lacs (▼0.8% YoY)
- PAT ₹114.42 Lacs vs ₹91.69 Lacs (▲24.8% YoY)
- EBITDA Margin 3.37% vs 3.84% (▼47bps)
Financials
Positive
2026-08-12 18:08
- Q1 FY27 Standalone Revenue ₹69.51 Cr vs ₹61.36 Cr (▲13.27% YoY)
- EBITDA ₹2.20 Cr vs ₹2.36 Cr (▼6.68% YoY)
- PAT ₹1.14 Cr vs ₹0.92 Cr (▲24.79% YoY)
- EBITDA Margin 3.16% vs 3.84% (▼68bps)
Governance
Neutral
2026-08-07 17:55
- Board Meeting on August 12, 2026, to consider and approve un-audited financial results for the quarter ended June 30, 2026.
- The trading window remains closed until 48 hours after the results announcement.
Routine
Neutral
2026-06-30 15:53
- Trading window for Designated Persons to remain closed from July 1, 2026.
- It will reopen 48 hours after declaration of unaudited financial results for the quarter ended June 30, 2026.
- The Board Meeting date for approval of results will be intimated separately.